Although the accumulation of cholesterol and other lipidic material is unquestionably important in atherogenesis, the reasons why this material progressively accumulates, rather than being effectively cleared by phagocytic cells such as macrophages, are not completely understood. We hypothesize that atheromatous lesions may represent "death zones" that contain toxic materials such as oxysterols and in which monocytes/macrophages become dysfunctional and apoptotic. Indeed, cathepsins B and L, normally confined to the lysosomal compartment, are present in the cytoplasm and nuclei of apoptotic (caspase-3-positive) macrophages within human atheroma. The possible involvement of oxysterols is suggested by experiments in which cultured U937 and THP-1 cells exposed to 7-oxysterols similarly undergo marked lysosomal destabilization, caspase-3 activation, and apoptosis. Like macrophages within atheroma, intralysosomal cathepsins B and L are normally present in the cytoplasm and nuclei of these oxysterol-exposed cells. Lysosomal destabilization, cathepsin release, and apoptosis may be causally related, because inhibitors of cathepsins B and L suppress oxysterol-induced apoptosis. Thus, toxic materials such as 7-oxysterols in atheroma may impair the clearance of cholesterol and other lipidic material by fostering the apoptotic death of phagocytic cells, thereby contributing to further development of atherosclerotic lesions. (Arterioscler Thromb Vasc Biol. 2001;21:1124-1130.)
T he most obvious characteristic of atherosclerotic lesions is an abundance of cholesterol and other lipidic material that, in advanced lesions, is often referred to as "gruel." It is not fully understood, however, why this material persists rather than being cleared by the professional phagocytes such as monocytes/macrophages that typically abound in such lesions. Our investigations have centered on the ideacertainly not original with us-that components of these atherosclerotic lesions may be cytotoxic and, in particular, cause dysfunction and death of phagocytic cells recruited to the site. Our particular focus has been on oxidized lipids, including oxidized LDL (oxLDL) and associated oxysterols. These are known to be abundant in atherosclerotic lesions and to be toxic to a variety of vascular cells. [1] [2] [3] [4] [5] [6] Furthermore, increased plasma concentrations of 7␤-hydroxycholesterol (7␤-OH) are related to enhanced risk for cardiovascular diseases. 7 Among the oxysterols, 7␤-OH and 7-ketocholesterol (7-keto) are major components of oxLDL. 8 Apoptosis is a prominent feature of atherosclerotic lesions and may be associated with instability and remodeling of atheroma plaques. 9, 10 Previous investigations have suggested that destabilization of lysosomes might be an important early event in apoptosis triggered by a variety of agonists. This has led us to the idea that minor leakage of lysosomal proteases and other hydrolytic enzymes into the cytosol of cells may actually be an initiating event in apoptosis. [11] [12] [13] [14] [15] Two lysosomal cysteine proteases, cathepsins B and L, have been identified as caspase-processing enzymes and inducers of apoptosis. 16, 17 Therefore, in the present investigations, we examined macrophages within human atherosclerotic plaque for evidence of the release of lysosomal enzymes, in particular cathepsins B and L. We also sought to determine whether the release of cathepsins might coincide with the occurrence of typical signs of apoptosis in these cells. Finally, we tested the effects of one potential class of toxins, 7-oxysterols, on macrophage cell lines to determine whether the features found in macrophages within atherosclerotic lesions might be reproduced by one known toxic component of the atherosclerotic plaque. Overall, the results support the concept that the interior of atheroma lesions may be a "death zone" in which various cytotoxic plaque components cause the dysfunction and, ultimately, death of phagocytes that would otherwise be capable of clearing the debris and resolving the lesion.
Methods

Immunohistochemistry
Segments from normal human mammary arteries (nϭ4), atherosclerotic coronary arteries (nϭ5), and thoracic aortas (nϭ5) were collected from clinical autopsy cases. For visualization of cathepsins B and L, serial sections were overlaid with goat polyclonal antihuman cathepsins B-and L-reactive primary antibodies (Santa Cruz Biotechnology, Inc), respectively, followed by an alkaline phosphatase-conjugated swine anti-goat antibody. The alkaline phosphatase activity was visualized with 4-benzoylamino-2,5diethoxybenzenediazonium chloride (Sigma Chemical Co).
Immunoreactivity of the active form of caspase-3 was detected by incubating the samples with polyclonal rabbit anti-human active caspase-3 (Pharmingen) followed by a goat anti-rabbit peroxidase conjugated antibody (DAKO Corp). The peroxidase activity was localized by use of 3-amino-9-ethylcarbazole (Sigma).
To determine the relationship between caspase-3 and lysosomal cathepsins within the same atherosclerotic lesions, double immunostaining of cathepsins B and L and caspase-3 was performed. The immunodetection of macrophages with monoclonal anti-CD 68 antibodies (DAKO) was carried out as previously described. 10 As a negative control, the primary antibody was omitted. In all cases, endogenous peroxidase was blocked by preincubation with 3% H 2 O 2 . To avoid nonspecific antibody adsorption, preimmune serum of the same origin as the secondary antibody was used before primary antibody application. All antibodies were diluted with 1% BSA.
Cells and Culture Conditions
Cells from 2 human monocytic cell lines, U-937 and THP-1, were cultured in RPMI-1640 culture medium containing 10% FCS. For the experiments, cells were directly exposed to either 7␤-OH or 7-keto (0 to 56 mol/L), dissolved in ethanol for 6 to 48 hours or pretreated with 75 g/mL E64 [trans-epoxysuccinyl-L-leucylamido-(4-guanidino)butane, Sigma] for 14 hours, and then exposed to 7␤-OH and 7-keto for another 24 hours. A selective inhibitor of cathepsins B and L, Z-Phe-Ala-fluoromethylketone (Z-FAFMK) (Enzyme Systems Products), was applied (50 mol/L) for 24 hours together with 7␤-OH and 7-keto in some experiments. The solvent, ethanol (maximum 0.4%), had no toxic effect. Cell membrane integrity was determined by trypan blue dye exclusion test, lactate dehydrogenase (LDH) assay, and propidium iodide (PI) staining.
Assessment of Apoptosis
For morphological assessment, cultured cells were stained with Wright-Giemsa and examined by light microscopy as previously described. 14 The cells were also examined by transmission electron microscopy as previously described. 15 Caspase-3 activity of the cultured cells was assayed by spectrofluorometry. The cells were incubated with 20 mol/L Ac-DEVD-AMC (Pharmingen) at 37°C for 2 hours. The fluorescence intensity of the liberated 7-amino-4-methylcoumarin was measured at excitation 380/emission 435 nm.
Apoptosis of both cultured cells and sections from normal and atherosclerotic human arteries was detected by the terminal dUTP nick end-labeling (TUNEL) technique using ApopTag in situ apoptosis detection kit according to the manufacturer's instructions (Oncor Inc). Apoptotic and necrotic cells were simultaneously detected by flow cytometry by use of an annexin V-PI kit according to the manufacturer's instruction (Roche Diagnostics GmbH).
Determination of Lysosomal Stability
Lysosomal stability was assessed by the acridine orange (AO) vital uptake technique as described previously. 11, 12 The intensity of AO-induced red fluorescence was measured by static cytofluorometry (50 cells per sample) or by FACScan (Becton-Dickinson) flow cytofluorometer (10 000 cells per sample) fitted with Lysis II software. 12
Assessment of Cathepsin B and L Activity
Control and E64-treated cells were collected by centrifugation and washed twice with PBS. Cell pellets were lysed with 0.1% Triton X-100, and the activities of the lysosomal cysteine proteinases, cathepsins B and L, were measured with Z-Arg-Arg-7-amido-4methylcoumarin and Z-Phe-Arg-7-amido-4-methylcoumarin as the respective substrates.
Statistics
Statistical comparisons were made by use of the Mann-Whitney U test. Differences were considered significant at values of PՅ0.05.
Results
Arterial Cathepsins B and L and Caspase-3 Immunohistochemistry
Normal human arteries contain few or no cathepsin B-and L-positive cells. In atherosclerotic lesions, there is a lesiondependent enhanced expression of cathepsin B (Figure I, see online at http://atvb.ahajournals.org), mainly in macrophages and smooth muscle cells in the lesions (cathepsin L showed the same pattern). In support of a possible causal relationship between lysosomal leakage and cellular apoptosis, in the same plaques the presence of immunoreactive cathepsins B and L (Figure 1 , middle) colocalized with apoptotic macrophages, as assessed by both CD68 and TUNEL staining (Figure 1, top) . Interestingly, immunoreactive cathepsins B and L were seen not only in the cytoplasm of arterial macrophages and in extracellular spaces but also in the nuclei of some apoptotic macrophages (Figure 1 , bottom right). This finding is in accord with earlier reports that translocation of cathepsin B may participate in apoptosis by proteolytic attack on nuclear contents. 18, 19 By double immunohistochemistry, both cathepsins B and L were found colocalized with caspase-3-positive areas in the lesions, especially in advanced fibrous plaques (Figure 1, bottom) . . Cathepsin B appears as blue and caspase 3 activity as red, and they are coexpressed in the same lesions. In some cells, cathepsin B is seen not only in the cytosol but also within nuclei (arrows). Magnification ϫ400.
Lysosomal Destabilization and 7-Oxysterol Cytotoxicity
The in vivo findings reported above support the general concept that the contents of atherosclerotic plaque might be cytotoxic, perhaps by engendering lysosomal instability, release of lysosomal material such as cathepsins, and subsequent apoptosis. As a model system for these events, we used the human monocytic cell lines U937 and THP-1, exposing them to varying doses of the oxysterols 7␤-OH and 7-keto.
Lysosomal integrity was assayed by static and flow cytofluorometry after AO staining. AO is a lysosomotropic weak base and a metachromatic fluorophore that accumulates in the lysosomal compartment as a result of proton trapping. In normal cells it induces red granular lysosomal fluorescence on green light excitation. Cells with ruptured lysosomes, on the contrary, appear "pale" (diminished red fluorescence due to fewer intact lysosomes). Lysosomal destabilization caused by 7␤-OH and 7-keto (28 mol/L) was clearly timedependent and occurred before apoptotic cell death. The number of pale cells increased to more than 3 times (7␤-OH) and 2 times (7-keto) that of untreated control cells after 12 hours of exposure (Figure 2 , top row), whereas there was no increased number of apoptotic or necrotic cells (Figure 2 , bottom row). After an exposure period of 24 hours, an even greater lysosomal rupture was evident, together with increased numbers of apoptotic and necrotic cells ( Figure 2) . Static cytofluorometry showed similar results. Exposure to cholesterol did not change red lysosomal fluorescence.
Apoptosis was also confirmed by the activation of caspase-3 (Ϸ250% and 150% of control values in 7␤-OH and 7-keto exposed cells, respectively) and the occurrence of DNA fragmentation as determined by TUNEL (Ϸ500% and 300% of control values in 7␤-OH-and 7-keto-exposed cells, respectively). As assessed by transmission electron microscopy, exposure to 28 mol/L 7␤-OH for 24 hours caused many U937 cells to exhibit typical apoptotic morphology, with condensation and margination of the nuclear chromatin, pyknosis, and/or nuclear fragmentation (Figure 3, B and C) . The apoptotic cells also exhibited other alterations, including increased cytosolic multivesicular inclusions (Figure 3 , B and C), which have been described earlier for apoptosis induced by oxysterols in endothelial cells, 18 in cultured plaquederived vascular smooth muscle cells, 19 and in macrophages. 20 These multivesicular inclusions in the cytosol of apoptotic cells are most likely formed by autophagocytosis of cellular organelles, such as mitochondria, during frustrated reparative attempts. Postapoptotic necrotic cells with fragmented or pyknotic nuclei and permeabilized membranes also were observed ( Figure 3D ). Similar ultrastructural alterations, caused by oxysterols, also were seen in THP-1 cells under the same conditions (data not shown).
Cellular plasma membranes remained intact during the first 12 hours of oxysterol exposure, and Ϸ80% (7␤-OH) and 95% (7-keto) of the cells were still intact after 24 hours of exposure to 28 mol/L of 7-oxysterols (Figure 2 , bottom row). The trypan blue exclusion test and LDH assay gave similar results. These cytotoxic effects were specific for oxysterols, inasmuch as native cholesterol (28 to 56 mol/L) or Ͻ0.4% ethanol had no effect on either cell membrane integrity or growth over a 48-hour period. Almost identical results were obtained with both cell lines.
Role of Cathepsins B and L in Apoptosis Induced by 7-Oxysterols
The expression and localization of lysosomal cathepsins were examined in U937 cells after exposure to 7-oxysterols. Normally, the cells display a granular immunoreactivity of cathepsins B and L, reflecting the lysosomal localization of these proteases. In contrast, oxysterol treatment caused enhanced cathepsin B and L immunoreactivity, no longer of a granular nature and dispersed throughout the cytoplasm of the cells. The apoptotic cells also showed pronounced cathepsins B and L, which localized with the condensed and shrunken nuclei (Figure 4) . These findings correspond well to the above observations in human atheroma, indicating that release of lysosomal cathepsins and their dispersion throughout the cell is associated with apoptotic cell death in these lesions. The activities of cathepsins B and L were significantly increased after 6 hours of exposure to 7-oxysterols and then gradually decreased (as assayed after 12 and 24 hours). The early increase of the lysosomal enzymes may represent induction of autophagocytotic repair, whereas the later decline may be due to autodegradation when the enzymes are released to the cytosol during the apoptotic process.
To determine whether the release of lysosomal cathepsins and apoptotic cell death might be causally associated, we investigated the effects of E64 (inhibits mainly the cysteine proteases cathepsins B, H, and L) 21 and the selective inhibitor of cathepsins B and L, Z-FAFMK, on 7-oxysterol-induced apoptosis. Because E64 is relatively membrane-impermeable, a high concentration (75 g/mL) was applied. Neither inhibitor caused any changes in cell growth or viability, but cathepsin B activity was reduced to Ϸ30% (E64) and 50% (Z-FAFMK), and cathepsin L activity to Ϸ12% (E64) and 40% (Z-FAFMK) of that of control cells. Both E64 and Z-FAFMK provided remarkable protection against oxysterolinduced apoptosis and necrosis. The inhibition of oxysterolinduced cell death by E64 was stronger than that of Z-FAFMK, which may be a result of the more extensive inhibition of cathepsins B and L by the former. As shown in Figure 5 , both E64 and Z-FAFMK significantly reduced the numbers of apoptotic cells, as well as the activation of caspase-3. These results may lend further support to the idea that leakage of lysosomal cysteine proteinases may play a crucial role in caspase-3 activation. Similar activation of caspase-3 and its prevention by E64 also were observed in THP-1 cells exposed to 7␤-OH (data not shown). Importantly, we did conduct control in vitro assays of the activity of caspase-3 (using both active caspase-3 and lysates of 7␤-OHtreated cells). The results showed that unlike caspases inhibitor Z-VAD, neither E64 nor Z-FAFMK had direct inhibitory effect on caspase-3 activity.
Discussion
The experiments reported above were focused on the question of why atheromatous lesions not only persist but increase in size despite the presence of cells, such as macrophages, that should ordinarily be capable of catabolizing the material within these lesions. Our overall hypothesis was that cytotoxic substances within atheroma lesions (such as, in this case, oxysterols) might not only suppress the catabolism of plaque material by macrophages but also predispose these cells, which are constantly recruited to atherosclerotic lesions, to apoptotic death. In fact, it was reported earlier that the catabolism of oxLDL and 7-oxysterols by macrophages is impaired, resulting in accumulation of unesterified or esterified cholesterol, cholesteryl hydroperoxide, and oxysterols [22] [23] [24] [25] and that the degradation of acetylated LDL by lysosomal enzymes is inhibited in the presence of added 7-keto. 25 Here, we report, as have others, 9,10,20 that human atherosclerotic lesions contain large numbers of apoptotic monocytes/macrophages. Furthermore, we find that these same cells show evidence of lysosomal destabilization. Two lyso-somal proteases in particular, cathepsins B and L, are present within the cytoplasm and nuclei of these apoptotic cells. Others 4 -6 have suggested that the progressive cell death within atheroma lesions might result from oxLDL cytotoxicity. OxLDL (which contains oxidized apoproteins as well as oxidized fatty acids and oxysterols) is present in substantial amounts in human and rabbit atheroma. 26 At least in in vitro models, both oxLDL and oxysterols have been found to be cytotoxic. 4 -6,8,18 We therefore elected to determine whether the cytotoxic effects that one of these components of oxLDL, 7-oxysterols, might have on the human monocytic cell lines U937 and THP-1 are similar to those observed in macrophages within human atherosclerotic lesions. Indeed, we find that micromolar concentrations of both 7␤-OH and 7-keto induce apoptotic and necrotic death of these cultured cells, in agreement with an earlier report. 9 Furthermore, as was the case for apoptotic macrophages within atherosclerotic lesions, we find that apoptosis induced by 7␤-OH and 7-keto is associated with lysosomal rupture, apparent release to the cytosol of cathepsins B and L, and activation of caspase-3. The possibility that released lysosomal enzymes might initiate the apoptotic process is strengthened by our observations that E64 (which mainly inhibits lysosomal cathepsins B, H, and L, but also the nonlysosomal proteases papain and calpain) and Z-FAFMK (a relatively selective inhibitor of cathepsins B and L) increase cell survival and partially suppress both apoptosis and activation of caspase-3 after exposure to 7-oxysterols. E64 also has been found to prevent cell death in other cell culture models, 27, 28 as well as neuronal death in an ischemic animal model. 29 Z-FAFMK effectively protects against apoptosis induced by P53 and several cytotoxic agents. 30 A growing body of evidence thus supports the role of released lysosomal cathepsins in the initiation of apoptosis: (1) apoptosis triggered by several different agonists is associated with lysosomal enzyme release 11-15 ; (2) leakage of lysosomal proteinases may lead to caspase activation 16, 17 ; and (3) cathepsin B and other lysosomal proteases are initiating agents for apoptosis, promoting the cleavage of Bid and resulting in the release of cytochrome c from mitochondria. 31, 32 Matrix degradation by proteolytic enzymes secreted from macrophages has been suggested to be an important factor in atherosclerotic plaque disruption. 33 Enzymes involved in the process include serine proteases, cysteine proteases, and matrix metalloproteinases. 34 Here, we report, for the first time, the occurrence of extensive immunoreactivity of cathepsins B and L in the nuclei of apoptotic cells within the atherosclerotic plaque and 7-oxysterol-treated apoptotic U937 cells. The mechanism(s) involved in the increase of cathepsins B and L immunoreactivity in apoptotic nuclei is not yet clear. The importance of the cysteine protease cathepsin B in matrix degradation and its association with matrix metalloproteinases was recently demonstrated. 35 The authors reported that, in addition to direct participation in tissue destruction, cathepsin B enhances the activity of matrix metalloproteinases by destroying their inhibitors. These findings, together with our results, indicate that lysosomal cathepsins may play an important role in the formation and destabilization of atherosclerotic plaques.
It should be emphasized that the concentrations of oxysterols used in the present experiments are substantially lower than those reported to exist in human atherosclerotic plaque. Therefore, there is good reason to suspect that cells that enter into atheroma will be damaged or killed by these and similar toxic plaque materials. If the interior of atheroma lesions does, indeed, represent a death zone for inflammatory cells such as monocytes/macrophages, this has implications for the overall disease process. First, this may lead to the accumulation of large numbers of dead and dying macrophages that ultimately release degradative enzymes, resulting in matrix degradation. Second, it is conceivable that products of these intoxicated cells will serve to attract further inflammatory cells to the lesion, thereby amplifying the inflammatory component and, perhaps, contributing to the overall growth of the plaque. Finally, these observations suggest one possible reason for the evident impotence of lesion-associated macrophages in clearance of the plaque material itself. These findings may open new perspectives for understanding the progression of atherosclerotic disease and, perhaps, generate new molecular targets for pharmaceutical control of plaque development.
